Post by Bio-Works Technologies
6,626 followers
โ๐๐ญ๐จ๐ฉ choosing between high yield and high throughputโ In monoclonal antibody (mAb) production, time is money - but speed should ๐ง๐๐ฏ๐๐ซ come at the expense of your yield. Traditionally, pushing for shorter residence times leads to a massive ๐๐ซ๐จ๐ฉ in Dynamic Binding Capacity (DBC). ๐๐ฎ๐ญ it doesn't have to be that way. With WorkBeadsโข affimAb Edge, we have ๐๐ก๐๐ง๐ ๐๐ the rules: โ ๐๐๐ญ๐๐ข๐ช๐ข ๐ฅ๐ง๐ค๐๐ช๐๐ฉ๐๐ซ๐๐ฉ๐ฎ: Process more batches faster without flushing valuable mAbs down the drain in the flow-through. โ ๐๐๐๐๐๐ง ๐๐ก๐ค๐ฌ ๐ง๐๐ฉ๐๐จ: Achieve up to 25% higher flow rates compared to industry standards, thanks to the rigid bead structure. โ ๐ฝ๐๐ฉ๐ฉ๐๐ง ๐ฅ๐ง๐ค๐๐๐จ๐จ ๐๐๐ค๐ฃ๐ค๐ข๐๐๐จ: Achieve a lower cost per purified gram of antibody. Why settle for compromises when you can have both? #mAbs #ProteinA #Bioprocessing #Chromatography #BioWorks #DownstreamProcessing #ProcessOptimization